Breaking
CNMo Gaoyi, director of China's State Council Information Office, appointed secretary of the Yunnan Provincial Committee of the Communist Party of ChinaBRVehicle rollover completely blocks section of BR-222 in CearáTRTerrible accident in Mardin! The car overturned into an irrigation canal: 6 people, including 4 children, from the same family, lost their livesBRMan is found dead with a gunshot wound to the head in a property with drugs in AçailândiaCNSaudi Arabian coalition forces intercept youth movement projectiles, warnings lifted in several Saudi citiesSAFrance warns of violence as Yellow Vests, students prepare for Paris protestsCNMore than 1,600 people have been affected by Typhoon Chiangpit in Taichung. Garbage collection and transportation will be carried out at regular intervals and at designated locations next year.UKStorm Boelo to bring 80mph gusts and heavy rain to parts of UKITMilan: bad news for Amorim, Rabiot, Moreira and Gila knocked outTRHistoric success in the world of oncology: Moderna's personalized mRNA cancer vaccine reduced the risk of recurrence by 42 percentCNMo Gaoyi, director of China's State Council Information Office, appointed secretary of the Yunnan Provincial Committee of the Communist Party of ChinaBRVehicle rollover completely blocks section of BR-222 in CearáTRTerrible accident in Mardin! The car overturned into an irrigation canal: 6 people, including 4 children, from the same family, lost their livesBRMan is found dead with a gunshot wound to the head in a property with drugs in AçailândiaCNSaudi Arabian coalition forces intercept youth movement projectiles, warnings lifted in several Saudi citiesSAFrance warns of violence as Yellow Vests, students prepare for Paris protestsCNMore than 1,600 people have been affected by Typhoon Chiangpit in Taichung. Garbage collection and transportation will be carried out at regular intervals and at designated locations next year.UKStorm Boelo to bring 80mph gusts and heavy rain to parts of UKITMilan: bad news for Amorim, Rabiot, Moreira and Gila knocked outTRHistoric success in the world of oncology: Moderna's personalized mRNA cancer vaccine reduced the risk of recurrence by 42 percent
